Clinical Significance of Anti-U1 Ribonucleoprotein Antibody in Anti-Topoisomerase I Antibody-Positive Systemic Sclerosis Patients: A Retrospective Observational Study. acbr [Internet]. 2021 Jan. 20 [cited 2026 Sep. 17];5(1):76-84. Available from: https://fortunejournals.org/ojs/index.php/acbr/article/view/14819